Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-16 · accession 0001415889-25-013642 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-16 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +33.3K | 86.9K | +62% | $0 | |
| 2025-05-19 | 2025-05-16 | FENC | Raykov Rosty | Dir | S - Sale | $6.78 | -16.7K | 70.3K | -19% | -$113.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2025-05-16 | A | A | 33,334 | $0.00 | 86,921 | D | — | — | (F1) Represents shares released from restriction from shares awarded 5-16-2024. |
| 2 | Common | Common shares | 2025-05-16 | S | D | 16,667 | $6.78 | 70,254 | D | — | — | (F2) The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain restricted stock units. |